MSD in search for companies to acquire in Turkey


Dunya - Merck Sharp & Dohme or MSD Pharmaceuticals, having acquired its competitor Schering-Plough for USD 41 billion last year and become the world’s second largest pharmaceutical company, is now looking for companies in Turkey for a possible merger and acquisition. Marc Princen, MSD President for Eastern Europe, Middle East and Africa, said they are currently assessing the investment opportunities in Turkey and added, “We look forward to strengthening our presence in Turkey. Talks for acquisitions and local partnership deals with Turkish companies are going on”.

Turkey; Turkish pharmaceutical sector; drug maker; healthcare; acquisition; merger; Merck Sharp & Dohme; MSD; Schering-Plough; Marc Princen